Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 mars 2015 07h00 HE | Source: EPIRUS Biopharmaceuticals, Inc.

EPIRUS Biopharmaceuticals to Host Biosimilar Key Opinion Leader Meeting and Webcast on March 30

BOSTON, March 25, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...
23 mars 2015 16h35 HE | Source: EPIRUS Biopharmaceuticals, Inc.

EPIRUS Reports Fourth Quarter and Fiscal Year 2014 Financial Results

BOSTON, March 23, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...
11 mars 2015 07h00 HE | Source: EPIRUS Biopharmaceuticals, Inc.

EPIRUS to Report Fourth Quarter and Fiscal Year 2014 Financial Results on March 24, 2015

BOSTON, March 11, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...